ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions
2022/05/03 by Sameer M. Zuberi, Elaine Wirrell, Elissa Yozawitz +19 · 59 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Epilepsy research and treatment #Neonatal and fetal brain pathology #Metabolism and Genetic Disorders
paper · pdf · doi:10.1111/epi.17239
Abstract
The International League Against Epilepsy (ILAE) Task Force on Nosology and Definitions proposes a classification and definition of epilepsy syndromes in the neonate and infant with seizure onset up to 2 years of age. The incidence of epilepsy is high in this age group and epilepsy is frequently associated with significant comorbidities and mortality. The licensing of syndrome specific antiseizure medications following randomized controlled trials and the development of precision, gene-related therapies are two of the drivers defining the electroclinical phenotypes of syndromes with onset in infancy. The principal aim of this proposal, consistent with the 2017 ILAE Classification of the Epilepsies, is to support epilepsy diagnosis and emphasize the importance of classifying epilepsy in an individual both by syndrome and etiology. For each syndrome, we report epidemiology, clinical course, seizure types, electroencephalography (EEG), neuroimaging, genetics, and differential diagnosis. Syndromes are separated into self-limited syndromes, where there is likely to be spontaneous remission and developmental and epileptic encephalopathies, diseases where there is developmental impairment related to both the underlying etiology independent of epileptiform activity and the epileptic encephalopathy. The emerging class of etiology-specific epilepsy syndromes, where there is a specific etiology for the epilepsy that is associated with a clearly defined, relatively uniform, and distinct clinical phenotype in most affected individuals as well as consistent EEG, neuroimaging, and/or genetic correlates, is presented. The number of etiology-defined syndromes will continue to increase, and these newly described syndromes will in time be incorporated into this classification. The tables summarize mandatory features, cautionary alerts, and exclusionary features for the common syndromes. Guidance is given on the criteria for syndrome diagnosis in resource-limited regions where laboratory confirmation, including EEG, MRI, and genetic testing, might not be available.
Citations
Cited by
- Long‐term intellectual and developmental outcomes after pediatric epilepsy surgery: A systematic review and meta‐analysis
- Deep brain stimulation of the centromedian nucleus for drug‐resistant epilepsy in children: Quality‐of‐life and functional outcomes from the CHILD ‐ DBS registry
- Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy
- Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children
- Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum
- Long‐term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome
- Clinical and genetic landscape of epilepsies with absence seizures and single‐gene etiology
- Early neurological symptoms and epilepsy outcomes in individuals with the recurrent GABRG2 p.( Ala106Thr ) gain‐of‐function variant: Structural and phenotypic insights
- The genetic landscape and classification of infantile epileptic spasms syndrome requiring surgery due to suspected focal brain malformations
- Genetic complexity in pediatric onset epilepsy‐movement disorder syndromes: Insights from a cohort of 97 subjects
- Ketogenic diet for infantile epileptic spasms
- Syndromic and etiological classification predicts seizure freedom in childhood and youth onset epilepsy: A population‐based study from the Norwegian Mother, Father, and Child Cohort Study
- Real‐world use of cenobamate in pediatric focal epilepsies and developmental epileptic encephalopathies: A multicenter retrospective series
- Frontiers in EEG as a tool for the management of pediatric epilepsy: Past, present, and future
- GABRA2‐related encephalopathy: Identification of two phenotypes with distinctive electroclinical features
- Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real‐world study
- Genetic epilepsies with myoclonic seizures: Mechanisms and syndromes
- Comparative assessment of artificial intelligence chatbots' performance in responding to healthcare professionals' and caregivers' questions about Dravet syndrome
- Relationship between the time course of Burden of Amplitudes and Epileptiform Discharges scores and relapse in children with infantile epileptic spasms syndrome
- Epilepsy syndromes classification
- Psychopathology in children before and after epilepsy surgery: a prospective controlled study
- The epilepsy–autism phenotype associated with developmental and epileptic encephalopathies: New mechanism‐based therapeutic options
- Evaluating the effectiveness of medical therapy in infantile epileptic spasms syndrome due to surgically‐remediable lesions
- Bexicaserin for the treatment of seizures in developmental and epileptic encephalopathies: A phase 1b/2a trial ( PACIFIC )
- The multiple hit model of infantile and epileptic spasms: The 2025 update
- Haploinsufficiency of brain‐specific kinase BRSK1 causes epilepsy and neurodevelopmental disorders
- Prenatal betamethasone–postnatal N‐methyl‐D‐aspartic acid model of spasms: Update on mechanisms and treatments
- Neurologic impairment and brain microstructural–functional alterations in infantile spasms: A multimodal magnetic resonance imaging study
- Long‐term outcomes of a cohort of patients with pharmacoresistant neonatal epilepsy and negative brain MRI
- To the editors: SCN1A gain‐of‐function effects in Dravet syndrome: Insights into clinical phenotypes and therapeutic implications
- Prevalence and incidence of infantile epileptic spasms syndrome in India: A systematic review and meta‐analysis
- Neonatal seizures: Advances in diagnosis and management
- Comparative effectiveness of second‐line treatments for epileptic spasms
- Broadening the phenotype associated with pathogenic variants in the FGF12 gene: From developmental and epileptic encephalopathy to drug‐responsive epilepsy with favorable cognitive outcome
- Genetic Diagnosis Impacts Medical Management for Pediatric Epilepsies. [europepmc]
- Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children. [europepmc]
- Duration of epileptic seizure types: A data-driven approach. [europepmc]
- The Ketogenic Diet in Children with Epilepsy: A Focus on Parental Stress and Family Compliance. [europepmc]
- Drosophila melanogaster as a versatile model organism to study genetic epilepsies: An overview. [europepmc]
- Widespread genomic influences on phenotype in Dravet syndrome, a 'monogenic' condition. [europepmc]
- Predicting seizure outcome after epilepsy surgery: Do we need more complex models, larger samples, or better data? [europepmc]
- The landscape of infantile epileptic spasms syndrome in South Asia: peculiarities, challenges, and way forward. [europepmc]
- Utility of Exome Sequencing for Diagnosis in Unexplained Pediatric-Onset Epilepsy. [europepmc]
- Landscape of genetic infantile epileptic spasms syndrome-A multicenter cohort of 124 children from India. [europepmc]
- Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study. [europepmc]
- New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development. [europepmc]
- New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System. [europepmc]
- Revisiting the concept of drug-resistant epilepsy: A TASK1 report of the ILAE/AES Joint Translational Task Force. [europepmc]
- Movement Disorders in Patients With Genetic Developmental and Epileptic Encephalopathies. [europepmc]
- Dravet syndrome: A systematic literature review of the illness burden. [europepmc]
- Complexity in Genetic Epilepsies: A Comprehensive Review. [europepmc]
- STXBP6 Gene Mutation: A New Form of SNAREopathy Leads to Developmental Epileptic Encephalopathy. [europepmc]
- Myoclonus: Differential diagnosis and current management. [europepmc]
- An Update on Stiripentol Mechanisms of Action: A Narrative Review. [europepmc]
- ZFHX3 variants cause childhood partial epilepsy and infantile spasms with favourable outcomes. [europepmc]
- Genetic Advancements in Infantile Epileptic Spasms Syndrome and Opportunities for Precision Medicine. [europepmc]
- Targeting Kv7 Potassium Channels for Epilepsy. [europepmc]
- Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy. [europepmc]
- Mitochondrial Donation in a Reproductive Care Pathway for mtDNA Disease. [europepmc]
Related